Search Results 141-150 of 15242 for edward loftus

  1. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC) - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  2. A Study To Evaluate The Effectiveness And Safety Of MEDI2070 In Subjects With Active Moderate To Severe Crohn's Disease - Mayo Clinic

    Edward Loftus JR, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non ...

  3. Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies - Mayo Clinic

    Participating Mayo Clinic locations ; Rochester, Minn. Mayo Clinic principal investigator. Edward Loftus, M.D.. Closed for enrollment ...

  4. Open Label Study To Evaluate Long Term Efficacy, Safety And Tolerability Of Repeated Dosing In Subjects With Crohn's Disease And Who Participated And Successfully Completed M14-115 - Mayo Clinic

    Edward Loftus JR, M.D.. Closed-enrolling by invitation. What is this? (?). "Close". Not open to everyone who meets the eligibility criteria, but only those ...

  5. A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  6. A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  7. infants Archives - Mayo Clinic News Network

    Dr. Edward Loftus Jr. Also on the program, endocrinologist Dr. William Young Jr. will explain why the pituitary gland is known as the “master gland," and ...

  8. An Open-Label Extension Of RPC1063 As Therapy For Moderate To Severe Ulcerative Colitis - Mayo Clinic

    Edward Loftus JR, M.D.. Contact information: IBD Clinical Research Unit. (507) 284-5908. Closed for enrollment. More information. Publications. Publications are ...

  9. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Ip, W. K. Eddie Ph.D. Minnesota. Johnson, C Dan M.D.. Arizona. Kane, Sunanda V. M.D.. Minnesota. Larson, David W. M.D., M.B.A.. Minnesota. Loftus, Edward V. Jr ...

  10. Filgotinib In Long-Term Extension Study Of Adults With Crohn's Disease - Mayo Clinic

    Edward Loftus JR, M.D.. Contact information: IBD Clinical Research Unit. (507) 284-5908. Closed for enrollment. More information. Publications. Publications are ...